Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 29 for your search:
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: LAL-07OLD, NCT01366898

2.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 40 and over
Sponsor: Other
Protocol IDs: ASAPOL, NCT01549418

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: Over 18 to less than 75
Sponsor: Other
Protocol IDs: GELI, NCT02387086

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000577892, SINGAPORE-ICR-02, SINGAPORE-ASCOLT, SINGAPORE-07-32-LGI, ICR-02, NCT00565708

5.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 2010-018360-16, NCT01058902

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300-00002, P01CA108671, MPD-RC 112, NCT01259856

7.

Phase: Phase III
Type: Prevention
Status: Approved-not yet active
Age: 40 to 60
Sponsor: Other
Protocol IDs: CREAT, NCT01496521

8.

Phase: Phase III
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: TIPS-3, NCT01646437

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LC-ASPIRIN, ASPIRIN-13-08, NCT01936233

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409

11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: P14.152, NCT02301286

12.

Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NNSFC 81302455, NCT02326779

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UCI 07-47, NCT00578721

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: VICC BMT 1020, NCT01215344

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GCO 09-1300 001, P01CA108671, MPD-RC 111, NCT01259817

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-MM-PI-0345, NCT01380106

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: CH-BC-011, NCT01431053

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01006, N01-CN-2012-00031, HHSN2612012000311, 1300000502, UAZ2013-01-01, P30CA023074, N01CN00031, NCT02123849

20.

Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: 2013-0732, HHSN261201200034I, NCT02135497

21.

Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: ASPIDIA, NCT02323516

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2015-00061, 1403269898, HHSN2612012000311, UAZ2013-02-01, N01CN00031, P30CA023074, NCT02348203

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: V1010, NCT01612247

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: VICC THN 1227, NCI-2012-01800, P50CA090949, NCT01707823

25.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 12-264, NCT01763606
1   
New Search